A generic formulation indicated for Mental Health. Usage manages imbalances in brain chemistry to assist with the regulation of mood and behavioral stability.
Utilized to manage symptoms of schizophrenia and severe motor tics to support behavioral stability and alleviate agitation in patients with psychotic disorders.
Mechanism of Action
Haloperidol blocks dopamine receptors in the brain. By reducing the activity of dopamine, a chemical messenger often overactive in psychosis, it helps to quiet hallucinations, stabilize mood, and reduce involuntary movements or vocal tics.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
8–12 hours
Contraindications
Parkinson's disease, Dementia with Lewy bodies, Severe CNS depression, Coma, QT prolongation
Severe Adverse Events
Tardive dyskinesia, Neuroleptic malignant syndrome, Severe heart rhythm abnormalities, Seizures
Information for Haloperidol is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
